Related Experiment Video
Updated: Jul 26, 2025

09:14
Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
Published on: June 18, 2021
2.4K
Resolution of Cerebral Inflammation Following Subarachnoid Hemorrhage
Victor Patsouris1,2, Kinga G Blecharz-Lang3, Melina Nieminen-Kelhä3
1Institute of Experimental Neurosurgery, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany. victor.patsouris@charite.de.
Neurocritical Care
|June 22, 2023
Summary
Inflammation resolution after aneurysmal subarachnoid hemorrhage (SAH) is crucial for recovery. This study found that while tissue homeostasis is restored, key inflammatory markers remain elevated, indicating incomplete resolution and potential for further brain damage.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Aneurysmal subarachnoid hemorrhage (SAH) is a severe stroke with high mortality and disability.
- Cerebral inflammation, driven by microglia and cytokines, exacerbates brain injury post-SAH.
- Understanding the inflammatory resolution phase is critical for improving patient outcomes.
Purpose of the Study:
- To evaluate the inflammatory resolution phase following SAH in a mouse model.
- To identify indicators of incomplete inflammation resolution and potential for tertiary brain damage.
Main Methods:
- SAH was induced in mice via endovascular filament perforation.
- Microglia/macrophage activity and neuronal cell death were assessed using immunohistochemistry.
- Gene expression of proinflammatory mediators was analyzed using quantitative PCR at various time points post-SAH.
Main Results:
- Tissue homeostasis was restored by 1 month post-SAH, with reduced microglial accumulation and neuronal death.
- Elevated mRNA levels of interleukin-6 and tumor necrosis factor-α persisted at 1 and 2 months post-SAH, respectively.
- Interleukin-1β peaked on day 1, with no significant differences at later time points.
Conclusions:
- Molecular and histological data suggest incomplete brain inflammation resolution after SAH.
- Incomplete resolution impacts brain damage and patient outcomes.
- Therapeutic strategies accelerating the inflammatory resolution phase warrant consideration for SAH management.

